Close

Analyst Ratings for CRISPR Therapeutics (CRSP) [Neutrals]

All Latest Ratings for CRSP

CRSP Rating Summary

CRSP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRSP
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $79.07 (+47.2%) * Over Last 12-Mos
Rating Score: 5.2 / 10   Percentile Rank: 57%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/15/2024 Wolfe Research Andy Chen New Coverage Peerperform
(N/A)		 N/A
(N/A)		 72.78
(53.73)		 -26.17% Details
10/17/2023 Cantor Fitzgerald Olivia Brayer Downgrade Neutral
(Buy)		 N/A
(N/A)		 44.81
(53.73)		 19.91% Details